Hexacosanol

Hexacosanol has shown neuroprotective effects in early in vitro and in vivo studies. In vitro and in vivo animal studies have shown that Hexacosanol can inhibit glucose-stimulated insulin secretion. Hexacosanol has also been demonstrated to stimulate phagocytosis in cultured macrophages.

Children, nursing mothers, and women who are pregnant should avoid supplemental Hexacosanol due to a lack of long-term safety studies. This website is intended to educate and inform, and should not replace discussions with your doctor.